Epidemiology, prevention, and control of the number one foodborne illness. Human norovirus.

Infectious Disease Clinics of North America

Volumn 27, Issue 3, 2013, Pages 651-674

  DiCaprio, Erin ^a   Ma, Yuanmei ^a   Hughes, John ^b   Li, Jianrong ^a  

^a OHIO STATE UNIVERSITY   (United States)

^b THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

Acute gastroenteritis; Detection methods; Epidemiology; Foodborne illness; Human norovirus; Prevention and control strategies; Vaccine development

Indexed keywords

2 PROPANOL; ALCOHOL; CHLORINE DIOXIDE; HYDROGEN PEROXIDE; HYPOCHLORITE SODIUM; LIVE VACCINE; PLACEBO; PROTEIN VP1; QUATERNARY AMMONIUM DERIVATIVE; SUBUNIT VACCINE; VIRUS LIKE PARTICLE VACCINE; VIRUS PROTEIN; VIRUS VACCINE;

ABDOMINAL CRAMP; ACUTE GASTROENTERITIS; ANTIBODY DETECTION; CELLULAR IMMUNITY; DIARRHEA; DISEASE PREDISPOSITION; DISEASE TRANSMISSION; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIDEMIC; FOOD CONTAMINATION; FOOD POISONING; GENOTYPE; GNOTOBIOTICS; HOST SUSCEPTIBILITY; HUMAN; IMMUNE DEFICIENCY; IMMUNOAFFINITY CHROMATOGRAPHY; IMMUNOELECTRON MICROSCOPY; IMMUNOGLOBULIN PRODUCTION; INFECTION CONTROL; MULTIPLEX POLYMERASE CHAIN REACTION; NONHUMAN; NOROVIRUS; NOROVIRUS INFECTION; OPEN READING FRAME; PHENOTYPE; PREVALENCE; PROTEIN DOMAIN; REAL TIME POLYMERASE CHAIN REACTION; RECEPTOR BINDING; REVERSE TRANSCRIPTION LOOP MEDIATED ISOTHERMAL AMPLIFICATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; VACCINATION; VIRUS CAPSID; VIRUS DETECTION; VIRUS GENOME; VIRUS MORPHOLOGY; VIRUS PARTICLE; VIRUS SHEDDING; VOMITING;

ACUTE GASTROENTERITIS; DETECTION METHODS; EPIDEMIOLOGY; FOODBORNE ILLNESS; HUMAN NOROVIRUS; PREVENTION AND CONTROL STRATEGIES; VACCINE DEVELOPMENT;

ANTI-INFECTIVE AGENTS; ANTIVIRAL AGENTS; CALICIVIRIDAE INFECTIONS; FOODBORNE DISEASES; HUMANS; NOROVIRUS; VIRAL VACCINES;

EID: 84883559511     PISSN: 08915520     EISSN: 15579824     Source Type: Journal    
DOI: 10.1016/j.idc.2013.05.009     Document Type: Review

References (130)

1. Norovirus: Trends and outbreaks. Centers for Disease Control and Prevention. Available at:. Accessed March 19, 2012. http://www.cdc.gov/norovirus/trends-outbreaks.html.
2. Scallan E., Hoekstra R.M., Angulo F.J., et al. Foodborne illness acquired in the United States-major pathogens. Emerg Infect Dis 2011, 17(1):7-15.
3. Hall A.J., Eisenbart V.G., Etingue A.L., et al. Epidemiology of foodborne norovirus outbreaks, United States, 2001-2008. Emerg Infect Dis 2012, 18(10):1566-1573.
4. Batz M.B., Hoffmann S., Morris J.G. Ranking the disease burden of 14 pathogens in food sources in the United States using attribution data from outbreak investigations and expert elicitation. JFood Prot 2012, 75(7):1278-1291.
5. Hoffmann S., Batz M.B., Morris J.G. Annual cost of illness and quality-adjusted life year losses in the United States due to 14 foodborne pathogens. JFood Prot 2012, 75(7):1292-1302.
6. Glass P.J., White L.J., Ball J.M., et al. Norwalk virus open reading frame 3 encodes a minor structural protein. JVirol 2000, 74(14):6581.
7. Lopman B.A., Reacher M.H., Vipond I.B., et al. Clinical manifestation of norovirus gastroenteritis in health care settings. Clin Infect Dis 2004, 39(3):318-324.
8. Rockx B., De Wit M., Vennema H., et al. Natural history of human calicivirus infection: a prospective cohort study. Clin Infect Dis 2002, 35(3):246-253.
9. Bok K., Green K.Y. Norovirus gastroenteritis in immunocompromised patients. NEngl J Med 2012, 367(22):2126-2132.
10. Glass R.I., Parashar U.D., Estes M.K. Norovirus gastroenteritis. NEngl J Med 2009, 361(18):1776-1785.
11. Kapikian A.Z., Wyatt R.G., Dolin R., et al. Visualization by immune electron-microscopy of a 27-nm particle associated with acute infectious nonbacterial gastroenteritis. JVirol 1972, 10(5):1075-1081.
12. Zheng D.P., Ando T., Fankhauser R.L., et al. Norovirus classification and proposed strain nomenclature. Virology 2006, 346(2):312-323.
13. Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention Updated norovirus outbreak management and disease prevention guidelines. MMWR Recomm Rep 2011, 60(RR-3):1-18.
14. Siebenga J.J., Vennema H., Zheng D.P., et al. Norovirus illness is a global problem: emergence and spread of norovirus GII.4 variants, 2001-2007. JInfect Dis 2009, 200(5):802-812.
15. Vega E., Barclay L., Gregoricus N., et al. Novel surveillance network for norovirus gastroenteritis outbreaks, United States. Emerg Infect Dis 2011, 17(8):1389-1395.
16. Centers for Disease Control and Prevention (CDC) Notes from the field: emergence of new norovirus strain GII.4 Sydney-United States, 2012. MMWR Morb Mortal Wkly Rep 2013, 62:55.
17. Donaldson E.F., Lindesmith L.C., Lobue A.D., et al. Norovirus pathogenesis: mechanisms of persistence and immune evasion in human populations. Immunol Rev 2008, 225(1):190.
18. Tan M., Jiang X. Norovirus and its histo-blood group antigen receptors: an answer to a historical puzzle. Trends Microbiol 2005, 13(6):285-293.
19. de Rougemont A., Ruvoen-Clouet N., Simon B., et al. Qualitative and quantitative analysis of the binding of GII.4 norovirus variants onto human blood group antigens. JVirol 2011, 85(9):4057-4070.
20. Le Pendu J., Ruvoen-Clouet N., Kindberg E., et al. Mendelian resistance to human norovirus infections. Semin Immunol 2006, 18(6):375-386.
21. Jiang X., Wang M., Graham D.Y., et al. Expression, self-assembly, and antigenicity of the Norwalk virus capsid protein. JVirol 1992, 66(11):6527.
22. Hardy M.E. Norovirus protein structure and function. FEMS Microbiol Lett 2005, 253(1):1-8.
23. Daughenbaugh K.F., Fraser C.S., Hershey J.W., et al. The genome-linked protein VPg of the Norwalk virus binds eIF3, suggesting its role in translation initiation complex recruitment. EMBO J 2003, 22(11):2852-2859.
24. Prasad B.V., Hardy M.E., Dokland T., et al. X-ray crystallographic structure of the Norwalk virus capsid. Science 1999, 286(5438):287.
25. Wobus C.E., Thackray L.B., Virgin H.W. Murine norovirus: a model system to study norovirus biology and pathogenesis. JVirol 2006, 80(11):5104-5112.
26. Doultree J.C., Druce J.D., Birch C.J., et al. Inactivation of feline calicivirus, a Norwalk virus surrogate. JHosp Infect 1999, 41(1):51-57.
27. Farkas T., Sestak K., Wei C., et al. Characterization of a rhesus monkey calicivirus representing a new genus of Caliciviridae. JVirol 2008, 82(11):5408-5416.
28. Lou F., Huang P., Neetoo H., et al. High-pressure inactivation of human norovirus virus-like particles provides evidence that the capsid of human norovirus is highly pressure resistant. Appl Environ Microbiol 2012, 78(15):5320-5327.
29. Feng K., Divers E., Ma Y., et al. Inactivation of a human norovirus surrogate, human norovirus virus-like particles, and vesicular stomatitis virus by gamma irradiation. Appl Environ Microbiol 2011, 77(10):3507-3517.
30. Marks P.J., Vipond I.B., Regan F.M., et al. Aschool outbreak of Norwalk-like virus: evidence for airborne transmission. Epidemiol Infect 2003, 131(1):727-736.
31. Teunis P.F., Moe C.L., Liu P., et al. Norwalk virus: how infectious is it?. JMed Virol 2008, 80(8):1468-1476.
32. Aoki Y., Suto A., Mizuta K., et al. Duration of norovirus excretion and the longitudinal course of viral load in norovirus-infected elderly patients. JHosp Infect 2010, 75(1):42-46.
33. Atmar R.L., Opekun A.R., Gilger M.A., et al. Norwalk virus shedding after experimental human infection. Emerg Infect Dis 2008, 14(10):1553-1557.
34. Armbrust S., Kramer A., Olbertz D., et al. Norovirus infections in preterm infants: wide variety of clinical courses. BMC Res Notes 2009, 2:96.
35. Ludwig A., Adams O., Laws H.J., et al. Quantitative detection of norovirus excretion in pediatric patients with cancer and prolonged gastroenteritis and shedding of norovirus. JMed Virol 2008, 80(8):1461-1467.
36. Fishman J.A. Infections in immunocompromised hosts and organ transplant recipients: essentials. Liver Transpl 2011, 17(Suppl 3):S34-S37.
37. Koo H.L., DuPont H.L. Noroviruses as a potential cause of protracted and lethal disease in immunocompromised patients. Clin Infect Dis 2009, 49(7):1069-1071.
38. Wingfield T., Gallimore C.I., Xerry J., et al. Chronic norovirus infection in an HIV-positive patient with persistent diarrhoea: a novel cause. JClin Virol 2010, 49(3):219-222.
39. Sukhrie F.H., Siebenga J.J., Beersma M.F., et al. Chronic shedders as reservoir for nosocomial transmission of norovirus. JClin Microbiol 2010, 48(11):4303-4305.
40. Siebenga J.J., Beersma M.F., Vennema H., et al. High prevalence of prolonged norovirus shedding and illness among hospitalized patients: a model for invivo molecular evolution. JInfect Dis 2008, 198(7):994-1001.
41. Seymour I.J., Appleton H. Foodborne viruses and fresh produce. JAppl Microbiol 2001, 91(5):759-773.
42. Graham D.Y., Jiang X., Tanaka T., et al. Norwalk virus infection of volunteers: new insights based on improved assays. JInfect Dis 1994, 170(1):34-43.
43. Phillips G., Lopman B., Tam C.C., et al. Diagnosing norovirus-associated infectious intestinal disease using viral load. BMC Infect Dis 2009, 9:63.
44. Herwaldt B.L., Lew J.F., Moe C.L., et al. Characterization of a variant strain of Norwalk virus from a food-borne outbreak of gastroenteritis on a cruise ship in Hawaii. JClin Microbiol 1994, 32(4):861-866.
45. Hjertqvist M., Johansson A., Svensson N., et al. Four outbreaks of norovirus gastroenteritis after consuming raspberries, Sweden, June-August 2006. Euro Surveill 2006, 11(9):E060907.1.
46. Falkenhorst G., Krusell L., Lisby M., et al. Imported frozen raspberries cause a series of norovirus outbreaks in Denmark, 2005. Euro Surveill 2005, 10(9):E050922.2.
47. Gaulin C.D., Ramsay D., Cardinal P., et al. Epidemic of gastroenteritis of viral origin associated with eating imported raspberries. Can J Public Health 1999, 90(1):37-40.
48. Le Guyader F.S., Mittelholzer C., Haugarreau L., et al. Detection of noroviruses in raspberries associated with a gastroenteritis outbreak. Int J Food Microbiol 2004, 97(2):179-186.
49. Dowell S.F., Groves C., Kirkland K.B., et al. Amultistate outbreak of oyster-associated gastroenteritis: implications for interstate tracing of contaminated shellfish. JInfect Dis 1995, 171(6):1497-1503.
50. Morse D.L., Guzewich J.J., Hanrahan J.P., et al. Widespread outbreaks of clam- and oyster-associated gastroenteritis. Role of Norwalk virus. NEngl J Med 1986, 314(11):678-681.
51. van Beek J., Ambert-Balay K., Botteldoorn N., et al. Indications for worldwide increased norovirus activity associated with emergence of a new variant of genotype II.4, late 2012. Euro Surveill 2013, 18(1):8-9.
52. Le Guyader F.S., Neill F.H., Dubois E., et al. Asemiquantitative approach to estimate Norwalk-like virus contamination of oysters implicated in an outbreak. Int J Food Microbiol 2003, 87(1-2):107-112.
53. Atmar R.L., Estes M.K. Diagnosis of noncultivatable gastroenteritis viruses, the human caliciviruses. Clin Microbiol Rev 2001, 14(1):15-37.
54. Green J., Norcott J.P., Lewis D., et al. Norwalk-like viruses: demonstration of genomic diversity by polymerase chain reaction. JClin Microbiol 1993, 31(11):3007-3012.
55. Antonishyn N.A., Crozier N.A., McDonald R.R., et al. Rapid detection of norovirus based on an automated extraction protocol and a real-time multiplexed single-step RT-PCR. JClin Virol 2006, 37(3):156-161.
56. Kageyama T., Kojima S., Shinohara M., et al. Broadly reactive and highly sensitive assay for Norwalk-like viruses based on real-time quantitative reverse transcription-PCR. JClin Microbiol 2003, 41(4):1548-1557.
57. Richards G.P., Watson M.A., Fankhauser R.L., et al. Genogroup I and II noroviruses detected in stool samples by real-time reverse transcription-PCR using highly degenerate universal primers. Appl Environ Microbiol 2004, 70(12):7179-7184.
58. Hoehne M., Schreier E. Detection of norovirus genogroup I and II by multiplex real-time RT-PCR using a 3'-minor groove binder-DNA probe. BMC Infect Dis 2006, 6:69.
59. Pang X.L., Preiksaitis J.K., Lee B. Multiplex real time RT-PCR for the detection and quantitation of norovirus genogroups I and II in patients with acute gastroenteritis. JClin Virol 2005, 33(2):168-171.
60. Green J., Henshilwood K., Gallimore C.I., et al. Anested reverse transcriptase PCR assay for detection of small round-structured viruses in environmentally contaminated molluscan shellfish. Appl Environ Microbiol 1998, 64(3):858-863.
61. O'Neill H.J., McCaughey C., Wyatt D.E., et al. Gastroenteritis outbreaks associated with Norwalk-like viruses and their investigation by nested RT-PCR. BMC Microbiol 2001, 1:14.
62. Nishimura N., Nakayama H., Yoshizumi S., et al. Detection of noroviruses in fecal specimens by direct RT-PCR without RNA purification. JVirol Methods 2010, 163(2):282-286.
63. Boxman I.L., Verhoef L., Dijkman R., et al. Year-round prevalence of norovirus in the environment of catering companies without a recently reported outbreak of gastroenteritis. Appl Environ Microbiol 2011, 77(9):2968-2974.
64. De Medici D., Suffredini E., Crudeli S., et al. Effectiveness of an RT-booster-PCR method for detection of noroviruses in stools collected after an outbreak of gastroenteritis. JVirol Methods 2007, 144(1-2):161-164.
65. Fukuda S., Takao S., Kuwayama M., et al. Rapid detection of norovirus from fecal specimens by real-time reverse transcription-loop-mediated isothermal amplification assay. JClin Microbiol 2006, 44(4):1376-1381.
66. Iturriza-Gomara M., Xerry J., Gallimore C.I., et al. Evaluation of the Loopamp (loop-mediated isothermal amplification) kit for detecting norovirus RNA in faecal samples. JClin Virol 2008, 42(4):389-393.
67. Yoda T., Suzuki Y., Yamazaki K., et al. Application of a modified loop-mediated isothermal amplification kit for detecting norovirus genogroups I and II. JMed Virol 2009, 81(12):2072-2078.
68. Duizer E., Pielaat A., Vennema H., et al. Probabilities in norovirus outbreak diagnosis. JClin Virol 2007, 40(1):38-42.
69. Castriciano S., Luinstra K., Petrich A., et al. Comparison of the RIDASCREEN norovirus enzyme immunoassay to IDEIA NLV GI/GII by testing stools also assayed by RT-PCR and electron microscopy. JVirol Methods 2007, 141(2):216-219.
70. Costantini V., Grenz L., Fritzinger A., et al. Diagnostic accuracy and analytical sensitivity of IDEIA norovirus assay for routine screening of human norovirus. JClin Microbiol 2010, 48(8):2770-2778.
71. Gray J.J., Kohli E., Ruggeri F.M., et al. European multicenter evaluation of commercial enzyme immunoassays for detecting norovirus antigen in fecal samples. Clin Vaccine Immunol 2007, 14(10):1349-1355.
72. Morillo S.G., Luchs A., Cilli A., et al. Norovirus 3rd generation kit: an improvement for rapid diagnosis of sporadic gastroenteritis cases and valuable for outbreak detection. JVirol Methods 2011, 173(1):13-16.
73. Siqueira J.A., Linhares Ada C., Oliveira Dde S., et al. Evaluation of third-generation RIDASCREEN enzyme immunoassay for the detection of norovirus antigens in stool samples of hospitalized children in Belem, Para, Brazil. Diagn Microbiol Infect Dis 2011, 71(4):391-395.
74. MacCannell T., Umscheid C.A., Agarwal R.K., et al. Guideline for the prevention and control of norovirus gastroenteritis outbreaks in healthcare settings. Infect Control Hosp Epidemiol 2011, 32(10):939-969.
75. Bruggink L.D., Witlox K.J., Sameer R., et al. Evaluation of the RIDA(®)QUICK immunochromatographic norovirus detection assay using specimens from Australian gastroenteritis incidents. JVirol Methods 2011, 173(1):121-126.
76. Bruins M.J., Wolfhagen M.J., Schirm J., et al. Evaluation of a rapid immunochromatographic test for the detection of norovirus in stool samples. Eur J Clin Microbiol Infect Dis 2010, 29(6):741-743.
77. Kirby A., Gurgel R.Q., Dove W., et al. An evaluation of the RIDASCREEN and IDEIAenzyme immunoassays and the RIDAQUICK immunochromatographic test for the detection of norovirus in faecal specimens. JClin Virol 2010, 49(4):254-257.
78. Park K.S., Baek K.A., Kim D.U., et al. Evaluation of a new immunochromatographic assay kit for the rapid detection of norovirus in fecal specimens. Ann Lab Med 2012, 32(1):79-81.
79. Thongprachum A., Khamrin P., Tran D.N., et al. Evaluation and comparison of the efficiency of immunochromatography methods for norovirus detection. Clin Lab 2012, 58(5-6):489-493.
80. Pyo D., Yoo J. New trends in fluorescence immunochromatography. J Immunoassay Immunochem 2012, 33(2):203-222.
81. Buchan B, Anderson N, Jannetto P, etal. Simultaneous detection of influenza A and its subtypes (H1, H3, 2009 H1N1), influenza B, and RSV A and B in respiratory specimens on an automated, random access, molecular platform. 21st European Congress of Clinical Microbiology and Infectious Diseases (ECCMID). Milan, May 7, 2011.
82. Predmore A., Li J. Enhanced removal of a human norovirus surrogate from fresh vegetables and fruits by a combination of surfactants and sanitizers. Appl Environ Microbiol 2011, 77(14):4829-4838.
83. Feliciano L., Li J., Lee J., et al. Efficacies of sodium hypochlorite and quaternary ammonium sanitizers for reduction of norovirus and selected bacteria during ware-washing operations. PLoS One 2012, 7(12):e50273.
84. Li J., Predmore A., Divers E., et al. New interventions against human norovirus: progress, opportunities, and challenges. Annu Rev Food Sci Technol 2012, 3:331-352.
85. Norovirus in healthcare facilities fact sheet. Centers for Disease Control and Prevention. Available at:. Accessed March 19, 2013. http://www.cdc.gov/hai/pdfs/norovirus/229110-ANoroCaseFactSheet508.pdf.
86. Tian P., Yang D., Jiang X., et al. Specificity and kinetics of norovirus binding to magnetic bead-conjugated histo-blood group antigens. JAppl Microbiol 2010, 109(5):1753-1762.
87. Bae J., Schwab K.J. Evaluation of murine norovirus, feline calicivirus, poliovirus, and MS2 as surrogates for human norovirus in a model of viral persistence in surface water and groundwater. Appl Environ Microbiol 2008, 74(2):477-484.
88. Baert L., Vandekinderen I., Devlieghere F., et al. Efficacy of sodium hypochlorite and peroxyacetic acid to reduce murine norovirus 1, b40-8, Listeria monocytogenes, and Escherichia coli o157:H7 on shredded iceberg lettuce and in residual wash water. JFood Prot 2009, 72(5):1047-1054.
89. Baert L., Uyttendaele M., Vermeersch M., et al. Survival and transfer of murine norovirus 1, a surrogate for human noroviruses, during the production process of deep-frozen onions and spinach. JFood Prot 2008, 71(8):1590-1597.
90. Gulati B.R., Allwood P.B., Hedberg C.W., et al. Efficacy of commonly used disinfectants for the inactivation of calicivirus on strawberry, lettuce, and a food-contact surface. JFood Prot 2001, 64(9):1430-1434.
91. Dawson D.J., Paish A., Staffell L.M., et al. Survival of viruses on fresh produce, using MS2 as a surrogate for norovirus. JAppl Microbiol 2005, 98(1):203-209.
92. Lou F., Neetoo H., Chen H., et al. Inactivation of a human norovirus surrogate by high-pressure processing: effectiveness, mechanism, and potential application in the fresh produce industry. Appl Environ Microbiol 2011, 77(5):1862-1871.
93. Lou F., Neetoo H., Li J., et al. Lack of correlation between virus barosensitivity and the presence of a viral envelope during inactivation of human rotavirus, vesicular stomatitis virus, and avian metapneumovirus by high-pressure processing. Appl Environ Microbiol 2011, 77(24):8538-8547.
94. Leon J.S., Kingsley D.H., Montes J.S., et al. Randomized, double-blinded clinical trial for human norovirus inactivation in oysters by high hydrostatic pressure processing. Appl Environ Microbiol 2011, 77(15):5476-5482.
95. Dancho B.A., Chen H., Kingsley D.H. Discrimination between infectious and non-infectious human norovirus using porcine gastric mucin. Int J Food Microbiol 2012, 155(3):222-226.
96. Atmar R.L., Bernstein D.I., Harro C.D., et al. Norovirus vaccine against experimental human Norwalk virus illness. NEngl J Med 2011, 365(23):2178-2187.
97. Patel M.M., Widdowson M.A., Glass R.I., et al. Systematic literature review of role of noroviruses in sporadic gastroenteritis. Emerg Infect Dis 2008, 14(8):1224-1231.
98. Mason H.S., Ball J.M., Shi J.J., et al. Expression of Norwalk virus capsid protein in transgenic tobacco and potato and its oral immunogenicity in mice. Proc Natl Acad Sci USA 1996, 93(11):5335-5340.
99. Zhang X.R., Buehner N.A., Hutson A.M., et al. Tomato is a highly effective vehicle for expression and oral immunization with Norwalk virus capsid protein. Plant Biotechnol J 2006, 4(4):419-432.
100. Ball J.M., Hardy M.E., Atmar R.L., et al. Oral immunization with recombinant Norwalk virus-like particles induces a systemic and mucosal immune response in mice. JVirol 1998, 72(2):1345.
101. Souza M., Cheetham S.M., Azevedo M.S., et al. Cytokine and antibody responses in gnotobiotic pigs after infection with human norovirus genogroup II.4 (HS66 strain). JVirol 2007, 81(17):9183-9192.
102. Souza M., Costantini V., Azevedo M.S., et al. Ahuman norovirus-like particle vaccine adjuvanted with ISCOM or MLT induces cytokine and antibody responses and protection to the homologous GII.4 human norovirus in a gnotobiotic pig disease model. Vaccine 2007, 25(50):8448.
103. Ball J.M., Graham D.Y., Opekun A.R., et al. Recombinant Norwalk virus-like particles given orally to volunteers: phase I study. Gastroenterology 1999, 117(1):40-48.
104. El-Kamary S, Pasetti M, Tacket C, etal. Phase 1 dose escalation, safety and immunogenicity of intranasal dry powder norovirus vaccine. 3rd International Calicivirus Conference. Cancun, November 10, 2007.
105. Tacket C, Frey S, Bernstein D, etal. Phase 1 dose-comparison, safety and immunogenicity of intranasal dry powder Norwalk VLP vaccine. 5th International Conference on Vaccines for Enteric Diseases. Malaga, September 9, 2009.
106. Bok K., Parra G.I., Mitra T., et al. Chimpanzees as an animal model for human norovirus infection and vaccine development. Proc Natl Acad Sci USA 2011, 108(1):325-330.
107. Smith G.L., Mackett M., Moss B. Infectious vaccinia virus recombinants that express hepatitis B virus surface antigen. Nature 1983, 302(5908):490-495.
108. Harrington P.R., Yount B., Johnston R.E., et al. Systemic, mucosal, and heterotypic immune induction in mice inoculated with Venezuelan equine encephalitis replicons expressing Norwalk virus-like particles. JVirol 2002, 76(2):730-742.
109. Guo L., Wang J., Zhou H., et al. Intranasal administration of a recombinant adenovirus expressing the norovirus capsid protein stimulates specific humoral, mucosal, and cellular immune responses in mice. Vaccine 2008, 26(4):460-468.
110. Guo L., Zhou H., Wang M., et al. Arecombinant adenovirus prime-virus-like particle boost regimen elicits effective and specific immunities against norovirus in mice. Vaccine 2009, 27(38):5233-5238.
111. Ma Y., Li J. Vesicular stomatitis virus as a vector to deliver virus-like particles of human norovirus: a new vaccine candidate against an important noncultivable virus. JVirol 2011, 85(6):2942.
112. Duan Y., Ma Y., Hughes J., et al. Avesicular stomatitis virus (VSV)-based human norovirus vaccine provides protection against norovirus challenge in a gnotobiotic pig model 2012, American Society for Virology, Madison (WI).
113. Sekaly R.P. The failed HIV Merck vaccine study: a step back or a launching point for future vaccine development?. JExp Med 2008, 205(1):7-12.
114. Desai R., Yen C., Wikswo M., et al. Transmission of norovirus among NBA players and staff, winter 2010-2011. Clin Infect Dis 2011, 53(11):1115-1117.
115. Repp K.K., Keene W.E. A point-source norovirus outbreak caused by exposure to fomites. J Infect Dis 2012, 205(11):1639-1641.
116. Dore B., Keaveney S., Flannery J., et al. Management of health risks associated with oysters harvested from a norovirus contaminated area, Ireland, February-March 2010. Euro Surveill 2010, 15(19):pii/19567.
117. Arvelo W., Sosa S.M., Juliao P., et al. Norovirus outbreak of probable waterborne transmission with high attack rate in a Guatemalan resort. J Clin Virol 2012 Sep, 55(1):8-11.
118. Wadl M., Scherer K., Nielsen S., et al. Food-borne norovirus-outbreak at a militarybase, Germany, 2009. BMC Infect Dis 2010, 10(30). 10.1186/1471-2334-10-30.
119. Koh S.J., Cho H.G., Kim B.H., et al. An outbreak of gastroenteritis caused by norovirus-contaminated groundwater at a waterpark in Korea. J Korean Med Sci 2011, 26(1):28-32.
120. Barrabeig I., Rovira A., Buesa J., et al. Foodborne norovirus outbreak: The role ofan asymptomatic food handler. BMC Infect Dis 2010, 10(269). 10.1186/1471-2334-10-269.
121. Yee E.L., Palacio H., Atmar R.L., et al. Widespread outbreak of norovirus gastroenteritis among evacuees of hurricane katrina residing in a large "Megashelter" In Houston, Texas: Lessons learned for prevention. Clin Infect Dis 2007, 44(8):1032-1039.
122. Becker K.M., Moe C.L., Southwick K.L., et al. Transmission of norwalk virus during football game. N Engl J Med 2000, 343(17):1223-1227.
123. Tuladhar E., Hazeleger W.C., Koopmans M., et al. Residual viral and bacterial contamination of surfaces after cleaning and disinfection. Appl Environ Microbiol 2012, 78(21):7769-7775.
124. Liu P., Yuen Y., Hsiao H.M., et al. Effectiveness of liquid soap and hand sanitizer against norwalk virus on contaminated hands. Appl Environ Microbiol 2009, 76(2):394-399.
125. Nowak P., Topping J.R., Fotheringham V., et al. Measurement of the virolysis of human gii.4 norovirus in response to disinfectants and sanitisers. J Virol Methods 2011, 174(1-2):7-11.
126. Park G.W., Barclay L., Macinga D., et al. Comparative efficacy of seven hand sanitizers against murine norovirus, feline calicivirus, and gii.4 norovirus. J Food Prot 2011, 73(12):2232-2238.
127. Li D., Baert L., Van Coillie E., Uyttendaele M. Critical studies on binding-based rt-pcr detection of infectious noroviruses. J Virol Methods 2011, 177(2):153-159.
128. Hudson J.B., Sharma M., Petric M. Inactivation of norovirus by ozone gas in conditions relevant to healthcare. J Hosp Infect 2007, 66(1):40-45.
129. Tacket C.O., Sztein M.B., Losonsky G.A., et al. Humoral, mucosal, and cellular immune responses to oral Norwalk virus-like particles in volunteers. Clin Immunol 2003, 108(3):241-247.
130. Ma Y., Li J. Vesicular stomatitis virus as a vector to deliver virus like particles of human norovirus: a new vaccine candidate against an important noncultivable virus. J Virol 2011, 85(6):2942-2952.